HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.

Abstract
On 80 occasions 4 iliac biopsy trephines and 4 iliac aspirations were performed in 37 children with neuroblastoma at various stages of the disease. In 38 of these procedures, tumour cells were detected. In 24% of cases, both trephines and aspirates were positive, whereas in 63% neuroblastoma cells were detected only on the trephines and in 13% only on the aspirates. In addition, in 37% of the stagings, only one out of the 8 investigations was abnormal. Only in one of 33 pathological cases, was BM involvement diagnosed on trephine imprint. No involvement was ever observed on tibial and sternal aspirates without iliac involvement. Immunological studies with two monoclonal antibodies HSAN 1-2 and UJ13A were performed on 56 occasions. Cytohistological and immunological studies were concordant in 39. In 3 studies, the antigens recognized by the two monoclonal antibodies were not expressed by the initial tumour and in 3 additional studies immunological results were falsely negative; but in 11 cases monoclonal antibodies identified residual malignancy despite normal cytohistology. From this study, biopsies appear more helpful to detect malignant cells than aspirates. Immunological staining clearly leads to a better definition of tumour cells in aspirates.
AuthorsM C Favrot, D Frappaz, O Maritaz, I Philip, B Fontaniere, O Gentilhomme, C Bailly, J M Zucker, J C Gentet, J Kemshead
JournalBritish journal of cancer (Br J Cancer) Vol. 54 Issue 4 Pg. 637-41 (Oct 1986) ISSN: 0007-0920 [Print] England
PMID3535865 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Biopsy
  • Biopsy, Needle
  • Bone Marrow (pathology)
  • Fluorescent Antibody Technique
  • Humans
  • Neuroblastoma (pathology, secondary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: